Preclinical testing of low dose valproate and niclosamide (VaN) as novel anti-myeloma therapy

Project Details

Short titlePreclinical testing of low dose valproate and niclosamide (VaN) as novel anti-myeloma therapy
StatusFinished
Effective start/end date1/09/1530/04/18

Funding

  • BLOODWISE